Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury
Authors:
- Heather E. MerryHMHeather E. Merry
- Alexander S. FarivarAFAlexander S. Farivar
- Anton S. McCourtieAMAnton S. McCourtie
- Michael S. MulliganMMMichael S. Mulligan
- 31 March 2008
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 135 (3) , 656-665
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Impact of a Lung Transplantation Donor–Management Protocol on Lung Donation and Recipient OutcomesAmerican Journal of Respiratory and Critical Care Medicine, 2006
- P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass modelEuropean Journal of Cardio-Thoracic Surgery, 2006
- Crosstalk Between Thrombosis and Inflammation in Lung Reperfusion InjuryThe Annals of Thoracic Surgery, 2006
- Lung transplantation: donor and recipient critical care aspectsCurrent Opinion in Critical Care, 2005
- Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Ischemia–Reperfusion–induced Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The role of proinflammatory cytokines in lung ischemia-reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Regulation of chemokine expression by cyclosporine a in alveolar macrophages exposed to hypoxia and reoxygenationThe Annals of Thoracic Surgery, 2002
- Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndromeThe Annals of Thoracic Surgery, 2002
- Reperfusion injury significantly impacts clinical outcome after pulmonary transplantationThe Annals of Thoracic Surgery, 2000